vitrification, new method of embryo cryopreservation: maribor experience
Clicks: 271
ID: 198805
2018
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Emerging Content
30.0
/100
271 views
28 readers
AI Quality Assessment
Not analyzed
Readership in this journal
EmergingRanked #56 of 231 articles by views in planta medica
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 231 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Background. Vitrification is a new, simpler and more rational way of cryopreservation of redundant embryos in in vitro fertilisation. The purpose of this study was to introduce vitrification of blastocysts in clinical practice and compared two commercial cryoprotectants.
Methods. We started vitrifying blastocysts in 2008. Two commercial vitrification protocols were used, Vitrification Cooling/Warming (MediCult, Denmark) – (MC), and Vitrification Freeze/Thaw (IrvineScientific, ZDA) – (IS). IS medium includes two cryoprotectants: dimethylsulfoxide (DMSO) and ethylene glycol, meanwhile MC medium contains only ethylene glycol. Among 1030 in vitro fertilizated cycles, we preserved redundant blastocysts in 404 (39.2 %) cycles in liquid nitrogen. At the begining MC vitrification protocol was used in 253 cycles and later IS protocol in 151 cycles. 127 transfers (248 devitrified blastocysts) were performed using MC protocol and 71 transfers (124 blastocysts) using IS protocol. We compared the survival rate of blastocysts, rate of clinical and ongoing pregnancies and miscarriages. Cycles with at least one optimal blastocyst were evaluated separately.
Results. Survival rate of vitrified blastocysts by IS protocol was statistically significantly higher than survival rate by MC protocol (88.7 % or 77 %; P = 0.0103). Implantation rate of devitrified blastocysts by IS and MC protocol are comparable (22.7 % or 17.8 %). The rate of miscarriages does not statistically differ between the protocols (18.2 % or 16.7 %). There are no statistically significant differences between IS and MC protocols in clinical (31.8 % or 24 %) and ongoing pregnancies (26.1 % or 20 %). Pregnancy rate in cycles with at least one optimal devitrified blastocyst is 45.7 % by IS protocol and 36.4 % by MC protocol. In the same cycles, the rate of miscarriages is 5.7 % by IS and 4.5 % by MC protocol.
Conclusions. Higher values in all parameters were by IS media, even though the differences were not statistically significant because of low number of cycles. The only statistically significant difference between protocols was in survival rate in favor of IS protocol. The study continues.
| Reference Key |
rogli2018zdravnikivitrification,
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | ;Petra Roglič;Martin Ivec;Borut Kovačič;Veljko Vlaisavljević |
| Journal | planta medica |
| Year | 2018 |
| DOI |
10.6016/ZdravVestn.2786
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.